Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Aug;30(3):134-42.
doi: 10.1055/s-0036-1584819.

Noninvasive Facial Rejuvenation. Part 2: Physician-Directed-Neuromodulators and Fillers

Ryan M Dickey  1 , Matthew R Louis  1 , Joshua A Cox  1 , Kriti Mohan  1 , Edward I Lee  1 , Marjory G Nigro  2
Affiliations
Review

Noninvasive Facial Rejuvenation. Part 2: Physician-Directed-Neuromodulators and Fillers

Ryan M Dickey et al. Semin Plast Surg. 2016 Aug.

Abstract

A proper knowledge of noninvasive facial rejuvenation is integral to the practice of a cosmetic surgeon. Noninvasive facial rejuvenation can be divided into patient- versus physician-directed modalities. Patient-directed facial rejuvenation combines the use of facial products such as sunscreen, moisturizers, retinoids, α-hydroxy acids, and various antioxidants to both maintain youthful skin as well as rejuvenate damaged skin. Physicians may recommend and often prescribe certain products, but patients are in control with this type of facial rejuvenation. On the other hand, physician-directed facial rejuvenation entails modalities that require direct physician involvement, such as neuromodulators, filler injections, laser resurfacing, microdermabrasion, and chemical peels. With the successful integration of each of these modalities, a complete facial regimen can be established and patient satisfaction can be maximized. This article is the second in a three-part series describing noninvasive facial rejuvenation. Here the authors discuss neuromodulators and fillers in detail, focusing on indications for use, techniques, and common side effects.

Keywords: fillers; neuromodulators; noninvasive facial rejuvenation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Our recommended upper face onabotulinumtoxinA (Botox Cosmetic; Allergan, Inc.) injection in women.
Fig. 2
Fig. 2
Our recommended upper face onabotulinumtoxinA (Botox Cosmetic; Allergan, Inc.) injection in men.
Fig. 3
Fig. 3
Botulinum toxin injection record (with permission, Botox Cosmetic; Allergan, Inc.).
Fig. 4
Fig. 4
Pre- and post-botulinum toxin injection to forehead and glabella.
Fig. 5
Fig. 5
Upper face danger zone for botulinum toxin injection.
Fig. 6
Fig. 6
(A) Pre- and (B) post-hyaluronic acid injection for lower eyelid rejuvenation.
Fig. 7
Fig. 7
(A) Pre- and (B) post-Sculptra (Galderma Laboratories) injection for lower face rejuvenation.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. American Society of Plastic Surgeons Plastic Surgery Statistics Report. 2015 Cosmetic Plastic Surgery Statistics. 2015 Available at: http://www.plasticsurgery.org/Documents/news-resources/statistics/2015-s.... Accessed February 15, 2016
    1. Carruthers A, Sadick N, Brandt F. et al.Evolution of facial aesthetic treatment over five or more years: a retrospective cross-sectional analysis of continuous onabotulinumtoxinA treatment. Dermatol Surg. 2015;41(6):693–701. - PubMed
    1. Matarasso S L Comparison of botulinum toxin types A and B: a bilateral and double-blind randomized evaluation in the treatment of canthal rhytides Dermatol Surg 20032917–13., discussion 13 - PubMed
    1. Carruthers J, Carruthers A. Botulinum toxin A in the mid and lower face and neck. Dermatol Clin. 2004;22(2):151–158. - PubMed
    1. Allen S B, Goldenberg N A. Pain difference associated with injection of abobotulinumtoxinA reconstituted with preserved saline and preservative-free saline: a prospective, randomized, side-by-side, double-blind study. Dermatol Surg. 2012;38(6):867–870. - PubMed